Renin-angiotensin and sympathetic nervous system contribution to high blood pressure in Schlager mice

Journal of Hypertension

Volumn 29, Issue 11, 2011, Pages 2156-2166

  Palma Rigo, Kesia ^a,b,c   Jackson, Kristy L ^a   Davern, Pamela J ^a   Nguyen Huu, Thu Phuc ^a   Elghozi, Jean Luc ^b,c   Head, Geoffrey A ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d MONASH UNIVERSITY   (Australia)

Author keywords

baroreflex gain; cardiovascular responses; renin angiotensin system; Schlager hypertensive mice; sympathetic nervous system

Indexed keywords

LOSARTAN; PENTOLONIUM TARTRATE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL RESEARCH; CONTROLLED STUDY; DRUG EFFECT; FEEDING; HEART RATE; HYPERTENSION; HYPOTENSION; LOCOMOTION; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTRAINT; STRESS; TELEMETRY;

EID: 80054120945     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834bbb6b     Document Type: Article

References (48)

1. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23:1052-1060.
2. Fisher JP, Fadel PJ. Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp Physiol 2010; 95:572-580.
3. Davern PJ, Nguyen-Huu T, La Greca L, Head GA. Role of the sympathetic nervous system in Schlager genetically hypertensive mice. Hypertension 2009; 54:852-859.
4. Davern PJ, Head GA. Role of the medial amygdala in mediating responses to aversive stimuli leading to hypertension. Clin Exp Pharmacol Physiol 2011; 38:136-143.
5. Guyton AC. Long-term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Physiol 1990; 259:R865-R877. (Pubitemid 20387146)
6. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: omplications for long term control of autonomic output. Clin Exp Pharmacol Physiol 1997; 24:96-101. (Pubitemid 27101497)
7. Davern PJ, Head GA. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 2007; 49:1170-1177. (Pubitemid 351664323)
8. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 2007; 9:228-235. (Pubitemid 46900043)
9. Keeton TK, Campbell WB. The pharmacologic alteration of renin release. Pharmacol Rev 1980; 32:81-227.
10. Iwao H, Nakamura N, Kim S, Ikemoto F, Yamamoto K, Schlager G. Reninangiotensin system in genetically hypertensive mice. Jpn Circ J 1984; 48:1270-1279. (Pubitemid 15181978)
11. Leckie BJ. The action of salt and captopril on blood pressure in mice with genetic hypertension. J Hypertens 2001; 19:1607-1613. (Pubitemid 32783779)
12. Butz GM, Davisson RL. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 2001; 5:89-97. (Pubitemid 33675206)
13. Jackson K, Head GA, Morris BJ, Chin-Dusting J, Jones E, La Greca L, et al. Reduced cardiovascular reactivity to stress but not feeding in renin enhancer knockout mice. Am J Hypertens 2007; 20:893-899. (Pubitemid 47176343)
14. Head GA, Lukoshkova EV, Burke SL, Malpas SC, Lambert EA, Janssen BJ. Comparing spectral and invasive estimates of baroreflex gain. IEEE Eng Med Biol Mag 2001; 20:43-52.
15. Billet S, Bardin S, Verp S, Baudrie V, Michaud A, Conchon S, et al. Gain-offunction mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J Clin Invest 2007; 117:1914-1925. (Pubitemid 47036325)
16. Adams DJ, Head GA, Markus MA, Lovicu FJ, van der Weyden L, Kö ntgen F, et al. Renin enhancer is critical for regulation of renin gene expression and control of cardiovascular function. J Biol Chem 2006; 281:31753-31761. (Pubitemid 46041440)
17. Davern PJ, Jackson KL, Nguyen-Huu T, La Greca L, Head GA. Cardiovascular responses to aversive and nonaversive stressors in Schlager genetically hypertensive mice. Am J Hypertens 2010; 23:838-844.
18. Davern P, Chen D, Head G, Chavez C, Walther T, Mayorov D. The role of AT1a receptors in cardiovascular reactivity and neuronal activation following aversive stress in mice. Hypertension 2009; 54:1262-1268.
19. Snedecor GW, Cochran WG. Statistical methods. Ames, Iowa: Iowa State University Press; 1980.
20. Korner PI, Badoer E, Head GA. Cardiovascular role of the major noradrenergic cell groups in the rabbit: analysis based on 6-hydroxydopamine- induced transmitter release. Brain Res 1987; 435:258-272. (Pubitemid 18009795)
21. Matthews JN, Campbell MJ. Adjusting for baseline: change or percentage change. Stat Med 1992; 11:1624-1626.
22. Fennessy PA, Godwin S, Head GA, Campbell JH, Campbell GR. Shortterm and long-term cardiovascular actions of different doses of perindopril in the rabbit. Pharmacol Res 1996; 34:135-141. (Pubitemid 27076004)
23. Billet S, Bardin S, Tacine R, Clauser E, Conchon S. The AT1A receptor 'gain-of-function' mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II. Am J Physiol Endocrinol Metab 2006; 290:E840-E848.
24. Wong PC, Price WA Jr, Chiu AT, Duncia JV, Carini DJ, Wexler RR, et al. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. J Hypertens 1990; 15:459-468. (Pubitemid 20148035)
25. Lantelme P, Lo M, Luttenauer L, Sassard J. Pivotal role of the reninangiotensin system in Lyon hypertensive rats. Am J Physiol 1997; 42:R1793-R1799. (Pubitemid 27518134)
26. Harrap SB, Doyle AE. Long-term blood pressure effects of angiotensin in SHR are developmental stage-specific. In: Sassard J, editor. Genetic hypertension. Paris: Inserm/Libbey; 1992. pp. 507-509.
27. Head GA, Minami N. Importance of cardiac but not vascular hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke prone rats. Am J Med 1992; 92:S54-S59.
28. Uddin M, Harris-Nelson N. Renin activity and angiotensin I concentration in genetically selective inbred line of hypertensive mice. Biochem Biophys Res Commun 2004; 316:842-844. (Pubitemid 38368029)
29. Uddin M, Polley-Mandal M, Beg OU. Kallikrein-like prorenin-converting enzymes in inbred hypertensive mice. Biochem Biophys Res Commun 2003; 304:724-728. (Pubitemid 36513548)
30. Barrett JD, Eggena P. The influence of acute stress on active and inactive renin in the rat. Clin Exp Hypertens A 1986; 8:1171-1178. (Pubitemid 16008208)
31. Davern PJ, Jackson KL, Nguyen-Huu T, La Greca L, Head GA. Cardiovascular reactivity and neuronal activation to stress in Schlager genetically hypertensive mice. Neuroscience 2010; 170:551-558.
32. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995; 25:1111-1115.
33. Zhuo JL, Song KF, Abdelrahman A, Mendelsohn F. Blockade by intravenous losartan of AT(1) angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol 1994; 21:557-567. (Pubitemid 24255682)
34. Song KF, Zhuo JL, Mendelsohn FAO. Access of peripherally administered DuP-753 to rat Brain angiotensin-II receptors. Br J Pharmacol 1991; 104:771-772.
35. Collister JP, Osborn JW. Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats. Am J Physiol 1998; 274:R357-R366.
36. Jezova D, Ochedalski T, Kiss A, Aguilera G. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. J Neuroendocrinol 1998; 10:67-72. (Pubitemid 28055040)
37. MayorovDN, HeadGA. AT1-receptors in the RVLM mediate pressor responses to emotional stress in rabbits. Hypertension 2003; 41:1168-1173. (Pubitemid 36548621)
38. De Matteo R, Head GA, Mayorov DN. Angiotensin II in dorsomedial hypothalamus modulates cardiovascular arousal caused by stress but not feeding in rabbits. Am J Physiol 2006; 290:R257-R264.
39. Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. J Auton Nerv Syst 1990; 30:91-100. (Pubitemid 20192822)
40. Mayorov DN, Head GA. Ionotropic glutamate receptors in the rostral ventrolateral medulla mediate sympathetic responses to acute stress in conscious rabbits. Auton Neurosci 2002; 98:20-23. (Pubitemid 34627009)
41. Gaudet E, Blanc J, Elghozi JL. Role of angiotensin II and catecholamines in blood pressure variability responses to stress in SHR. Am J Physiol 1996; 39:R1265-R1272.
42. Dodt C, Breckling U, Derad I, Fehm HL, Born J. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997; 30:71-76. (Pubitemid 27306349)
43. Bendle RD, Malpas SC, Head GA. Role of endogenous angiotensin II on sympathetic reflexes in conscious rabbits. Am J Physiol 1997; 272:R1816-R1825.
44. Bechir M, Enseleit F, Chenevard R, Luscher TF, Noll G. Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension. Am J Cardiol 2005; 95:129-131. (Pubitemid 40051129)
45. Huang J, Hara Y, Anrather J, Speth RC, Iadecola C, Pickel VM. Angiotensin II subtype 1A (AT1A) receptors in the rat sensory vagal complex: subcellular localization and association with endogenous angiotensin. Neuroscience 2003; 122:21-36. (Pubitemid 37329945)
46. Kasparov S, Butcher JW, Paton JF. Angiotensin II receptors within the nucleus of the solitary tract mediate the developmental attenuation of the baroreceptor vagal reflex in preweaned rats. J Auton Nerv Syst 1998; 74:160-168. (Pubitemid 29054752)
47. Smith PA, Graham LN, Mackintosh AF, Stoker JB, Mary DA. Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol 2002; 40:126-132. (Pubitemid 34701387)
48. Head G, Mihailidou A, Duggan K, Beilin L, Berry N, Brown M, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 2010; 340:c1104.